Published in Acta Derm Venereol on January 01, 1971
European erythema migrans disease and related disorders. Yale J Biol Med (1985) 1.11
Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst (1996) 2.28
Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol (2000) 1.76
Fatal hepatic failure with liposomal doxorubicin. Lancet (1993) 1.41
[Contact eczema in housewives. Update from 1986 with reference to results of epicutaneous tests in 2,633 patients]. Hautarzt (1998) 1.39
Traditional tattooing of the gingiva: an Eritrean folk medicine practice. Arch Dermatol (1988) 1.38
Langerhans cells and interdigitating reticulum cells in the thymus-dependent region in human dermatopathic lymphadenitis. Virchows Arch B Cell Pathol (1977) 1.27
Genetic heterogeneity of the ichthyosis, hypogonadism, mental retardation, and epilepsy syndrome. Clinical and biochemical investigations on two patients with Rud syndrome and review of the literature. Eur J Pediatr (1983) 1.06
The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network. Br J Dermatol (1998) 1.04
A family study of atopic dermatitis. Clinical and genetic characteristics of 188 patients and 2,151 family members. Arch Dermatol Res (1990) 1.01
Decline of infectious skin manifestations in the era of highly active antiretroviral therapy. AIDS (2000) 1.00
[Bacterial colonization of chronic wounds. Studies on outpatients in a university dermatology clinic with special consideration of ORSA]. Hautarzt (2004) 0.99
Nonoperative treatment of four esophageal perforations with hemostatic clips. Dis Esophagus (2007) 0.99
T-cell specific microenvironment in mycosis fungoides. Arch Dermatol Res (1976) 0.98
Transanal endoscopic tube decompression of acute colonic obstruction: experience with 51 cases. Surg Endosc (2008) 0.98
Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group. Br J Cancer (1996) 0.96
[The role of oxidative stress in the pathogenesis and therapy of chronic wounds]. Hautarzt (2002) 0.95
Mycosis fungoides: model for T-lymphocyte homing to the skin? Br J Dermatol (1976) 0.94
Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma. Lancet (2000) 0.92
Topical immunomodulators--progress towards treating inflammation, infection, and cancer. Lancet Infect Dis (2001) 0.90
Evaluation of metal allergies in patients with coronary stents. Contact Dermatitis (2002) 0.89
Melanoma erysipeloides: successful treatment by chemoimmunotherapy. Br J Dermatol (2000) 0.88
Acquired immune deficiency syndrome-related hyperkeratotic Kaposi's sarcoma with severe lymphoedema: report of five cases. Br J Dermatol (2000) 0.88
Successful treatment of a leg ulcer occurring in a rheumatoid arthritis patient under leflunomide therapy. J Eur Acad Dermatol Venereol (2005) 0.87
Downregulation of tapasin expression in progressive human malignant melanoma. Arch Dermatol Res (2003) 0.86
Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients. AIDS (1998) 0.86
Behçet's syndrome: treatment with recombinant leukocyte alpha-interferon. Arch Dermatol Res (1986) 0.85
Ethanol enhances the IFN-gamma, TGF-alpha and IL-6 secretion in psoriatic co-cultures. Br J Dermatol (1996) 0.85
[Bureau-Barrière syndrome of the hand. A case report on an unusual localization]. Hautarzt (2004) 0.84
Tyrosine phosphorylation in psoriatic T cells is modulated by drugs that induce or improve psoriasis. Dermatology (1995) 0.84
Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection. Br J Nutr (1996) 0.84
Immune response against human primary malignant melanoma: a distinct cytokine mRNA profile associated with spontaneous regression. Lab Invest (1998) 0.84
Homozygous deletion of the p16INK4a and the p15INK4b tumour suppressor genes in a subset of human sporadic cutaneous malignant melanoma. Br J Dermatol (1998) 0.83
[pH values in chronic wounds. Evaluation during modern wound therapy]. Hautarzt (2003) 0.83
Liposomal doxorubicin in AIDS-related Kaposi's sarcoma. Lancet (1993) 0.83
Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma. Diagn Mol Pathol (1992) 0.83
Ras gene mutations: a rare event in nonmetastatic primary malignant melanoma. J Invest Dermatol (1995) 0.83
Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin. Eur J Cancer (2001) 0.83
[Superficial spreading melanoma. Paget's melanoma]. Dtsch Med Wochenschr (1973) 0.82
Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45. Identification as melanocyte-specific Pmel 17 cDNA. Lab Invest (1995) 0.82
Calgranulin C is overexpressed in lesional psoriasis. J Invest Dermatol (2000) 0.81
Intracutaneous genetic immunization with autologous melanoma-associated antigen Pmel17/gp100 induces T cell-mediated tumor protection in vivo. J Invest Dermatol (2000) 0.81
Contact allergy in patients with periorbital eczema: an analysis of allergens. Data recorded by the Information Network of the Departments of Dermatology. Dermatology (1997) 0.80
Efficient expression of naked plasmid DNA in mucosal epithelium: prospective for the treatment of skin lesions. J Invest Dermatol (1998) 0.80
Successful treatment of stasis dermatitis with topical tacrolimus. Vasa (2004) 0.80
[Palmoplantar purpura in Duhring's herpetiform dermatitis]. Hautarzt (1989) 0.80
[Contact allergies in patients with eczema of the external ear canal. Results of the Information Network of Dermatological Clinics and the German Contact Allergy Group]. Hautarzt (2000) 0.80
Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy. Cancer Immunol Immunother (1997) 0.80
Lithium and psoriasis: cytokine modulation of cultured lymphocytes and psoriatic keratinocytes by lithium. Arch Dermatol Res (1996) 0.80
Patch test sensitization caused by para-tertiary-butylcatechol. Results of a prospective study with a dilution series. Contact Dermatitis (2001) 0.79
[Acrodermatitis chronica atrophicans with fibrous nodules and monoclonal gammopathy]. Arch Dermatol Forsch (1971) 0.79
[Cytochemistry of skin infiltrates in myelomonocytic leukemia]. Dtsch Med Wochenschr (1970) 0.79
[HIV-positive patient with multiple ulcers. Lues maligna]. Hautarzt (2003) 0.79
Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis. Antimicrob Agents Chemother (1993) 0.79
Using an Apple iPad(™) to assist fibreoptic intubation. Anaesthesia (2013) 0.79
[The histopathology of alopecia areata. With special reference to the duration, location and progession of hair loss]. Arch Dermatol Forsch (1971) 0.78
Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes. J Invest Dermatol (1998) 0.78
Endogenous interferon plasma levels and antipyrine pharmacokinetics in patients with viral infections. Int J Clin Pharmacol Ther Toxicol (1992) 0.78
Immunomodulatory properties of cimetidine in ARC patients. Clin Immunol Immunopathol (1988) 0.78
Topical treatment of warts and mollusca with imiquimod. Ann Intern Med (2000) 0.78
Increased activity of factor VIII coagulant associated with venous ulcer in a patient with Klinefelter's syndrome. J Eur Acad Dermatol Venereol (2005) 0.78
[Therapy of pseudolymphomas]. Z Hautkr (1980) 0.78
Granulocyte colony-stimulating factor treatment in AIDS patients. Clin Investig (1992) 0.78
Inhibition of T cell cAMP formation by cyclosporin A and FK506. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.78
Pimecrolimus in an adhesive ointment as a new treatment option for oral lichen planus. Br J Dermatol (2004) 0.77
HIV-1 RNA levels in cerebrospinal fluid and plasma correlate with AIDS dementia. AIDS (1998) 0.77
[Cutaneous manifestation of fungal infection]. Hautarzt (1990) 0.77
Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients. Eur J Med Res (1997) 0.77
Cimetidine and the immuno-response in healthy volunteers. J Invest Dermatol (1989) 0.77
Comparative effects of rifampin and/or probenecid on the pharmacokinetics of temazepam and nitrazepam. Int J Clin Pharmacol Ther Toxicol (1990) 0.77
[Value of the patient's own test substances in epicutaneous testing]. Hautarzt (1994) 0.77
[Treatment of methicillin-resistant Staphylococcus aureus (MRSA) as part of biosurgical management of a chronic leg ulcer]. Hautarzt (2002) 0.77
[Evoked potentials in neurologically asymptomatic persons during the early stages of HIV infection]. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb (1989) 0.77
Inhibitor of the release of mast cell mediators does not improve the psoriatic plaque. Skin Pharmacol (1995) 0.76
[Postphotochemotherapeutic eruptive lentigines]. Ann Dermatol Venereol (1983) 0.76
CD44 variant isoform v10 is expressed on tumor-infiltrating lymphocytes and mediates hyaluronan-independent heterotypic cell-cell adhesion to melanoma cells. Exp Dermatol (2003) 0.76
[Hypertrichosis lanuginosa acquisita in ulcerative colitis with colon cancer]. Hautarzt (1992) 0.76
Hyaluronan-independent adhesion of CD44H+ and CD44v10+ lymphocytes to dermal microvascular endothelial cells and keratinocytes. J Invest Dermatol (2001) 0.75
[Pimecrolimus (SDZ ASM 981). Current state of research]. Dtsch Med Wochenschr (2002) 0.75
Cyclosporin A, FK506 and dithranol after tyrosine-specific protein phosphorylation in HaCaT keratinocytes. Arch Dermatol Res (1995) 0.75
[Painful bruising syndrome]. Hautarzt (2001) 0.75
Megestrol for AIDS-related anorexia. Ann Intern Med (1995) 0.75
[Diagnosis of allergy in pregnancy]. Hautarzt (1989) 0.75
[Clinical, histological and immunohistochemical study of the early diagnosis of mycosis fungoides]. Z Hautkr (1983) 0.75
[Physiopathology and diagnosis of hair loss]. Schweiz Med Wochenschr (1971) 0.75
[Internal disease findings in Arndt-Gottron scleromyxedema]. Dtsch Med Wochenschr (1986) 0.75
[Goltz-Gorlin syndrome in a male]. Hautarzt (1987) 0.75
[In situ - demonstration of helper-T-lymphocytes in cutaneous malignant lymphomas by diaminopeptidase IV (DAP IV)]. Z Hautkr (1982) 0.75
Phenotypic heterogeneity of leukemic Sézary cells. Blut (1983) 0.75
[Recurrent mitigated erysipelas in severe combined immunodeficiency]. Hautarzt (2000) 0.75
[Occupational medicine aspects of cutaneous leishmaniasis]. Derm Beruf Umwelt (1987) 0.75
[Contact eczemas in housewives]. Hautarzt (1986) 0.75
In situ identification and enumeration of helper T lymphocytes in cutaneous malignant lymphomas by dipeptidyl-peptidase IV (DPP IV). J Cutan Pathol (1982) 0.75
Allergic contact dermatitis due to deer-fat cream (Hirschtalgcreme). Contact Dermatitis (2001) 0.75
[Sebaceous gland carcinoma of the neck]. Hautarzt (2001) 0.75
Management of malignant melanoma: new developments in immune and gene therapy. Clin Exp Dermatol (2000) 0.75
Occupational UVA-induced allergic photodermatitis in a welder due to hydrochlorothiazide and ramipril. Contact Dermatitis (2000) 0.75
Combined allergy to tolnaftate and nystatin. Contact Dermatitis (1985) 0.75
Hypersensitivity to mesna. Lancet (1985) 0.75